Emerging Infectious Diseases (Sep 2021)

Predictors of Nonseroconversion after SARS-CoV-2 Infection

  • Weimin Liu,
  • Ronnie M. Russell,
  • Frederic Bibollet-Ruche,
  • Ashwin N. Skelly,
  • Scott Sherrill-Mix,
  • Drew A. Freeman,
  • Regina Stoltz,
  • Emily Lindemuth,
  • Fang-Hua Lee,
  • Sarah Sterrett,
  • Katharine J. Bar,
  • Nathaniel Erdmann,
  • Sigrid Gouma,
  • Scott E. Hensley,
  • Thomas Ketas,
  • Albert Cupo,
  • Victor M. Cruz Portillo,
  • John P. Moore,
  • Paul D. Bieniasz,
  • Theodora Hatziioannou,
  • Greer Massey,
  • Mary-Beth Minyard,
  • Michael S. Saag,
  • Randall S. Davis,
  • George M. Shaw,
  • William J. Britt,
  • Sixto M. Leal,
  • Paul Goepfert,
  • Beatrice H. Hahn

DOI
https://doi.org/10.3201/eid2709.211042
Journal volume & issue
Vol. 27, no. 9
pp. 2454 – 2458

Abstract

Read online

Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2–specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.

Keywords